Marzieh Salehi
The University of Texas Health Science Center at San Antonio · Marzieh Salehi
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marzieh Salehi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:20 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07212868 · The Role of Glucagon in Glucose Metabolism in Humans With and Without Bariatric SurgeryThe University of Texas Health Science Center at San Antonio · recruiting · Non-Diabetic · principal investigator
- Ph4NCT06706284 · Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesMarzieh Salehi · recruiting · Spinal Cord Injuries, Type 2 Diabetes · principal investigator
- Early Ph1NCT02823665 · The Effects of Bariatric Surgeries on Glucose MetabolismThe University of Texas Health Science Center at San Antonio · recruiting · Post Bariatric Surgery, Gastric Bypass, Sleeve Gastrectomy · principal investigator
- Early Ph1NCT01803451 · Glucagon-like Peptide 1, Glucose Metabolism and Gastric BypassThe University of Texas Health Science Center at San Antonio · recruiting · Post-bariatric Surgery · principal investigator
- Early Ph1NCT00992901 · Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass SurgeryThe University of Texas Health Science Center at San Antonio · recruiting · Post Bariatricsurgery, Hypoglycemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Glucagon-mediated glycemic effect in humans with and without rerouted gut after bariatric surgeryR01DK141843 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2025 to 2026 · $781,758 awarded in 2026Grant number is on one of their registry trials
- Glycemic and Weight Loss Effects of Semaglutide in Subjects After Spinal Cord Injury and Type 2 DiabetesR01DK140144 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2024 to 2026 · $700,873 awarded in 2026Grant number is on one of their registry trials
- The Weight-Independent Effects of Bariatric Surgeries on Islet Cell FunctionR01DK105379 · NIDDK · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2015 to 2020 · $474,051 awarded in 2020Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:20 UTC. The ranking covers the 200 most relevant of 92 PubMed records, and a shared surname and initials can bring in a namesake. All 92 on PubMed
- Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.Eur Respir J · 2020258 citationsRCR 12.3
- A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19.Antimicrob Agents Chemother · 2020235 citationsRCR 10.2
- Complete supine percutaneous nephrolithotripsy comparison with the prone standard technique.J Endourol · 2008110 citationsRCR 5.6
- Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.Eur J Med Res · 2021105 citationsRCR 7.4
- 101 citationsRCR 9.2
- Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting.Tex Heart Inst J · 200776 citationsRCR 2.2
- Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial.Nephrol Dial Transplant · 201368 citationsRCR 3.0
- Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction.Arch Iran Med · 200764 citationsRCR 1.7
- Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial.Int J Antimicrob Agents · 202063 citationsRCR 2.8
- Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double-blind, randomized, and placebo-controlled trial.J Biochem Mol Toxicol · 201960 citationsRCR 3.5